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ABSTRACT
Regulation of ribonucleotide reductase (RNR) is im-
portant for cell survival and genome integrity in the
face of genotoxic stress. The Mec1/Rad53/Dun1
DNA damage response kinase cascade exhibits
multifaceted controls over RNR activity including
the regulation of the RNR inhibitor, Sml1. After
DNA damage, Sml1 is degraded leading to the
up-regulation of dNTP pools by RNR. Here, we
probe the requirements for Sml1 degradation and
identify several sites required for in vivo phosphor-
ylation and degradation of Sml1 in response to DNA
damage. Further, in a strain containing a mutation in
Rnr1, rnr1-W688G, mutation of these sites in Sml1
causes lethality. Degradation of Sml1 is dependent
on the 26S proteasome. We also show that degrad-
ation of phosphorylated Sml1 is dependent on the
E2 ubiquitin-conjugating enzyme, Rad6, the E3
ubiquitin ligase, Ubr2, and the E2/E3-interacting
protein, Mub1, which form a complex previously
only implicated in the ubiquitylation of Rpn4.
INTRODUCTION
DNA damage activates a checkpoint kinase cascade that
both halts the cell cycle and concurrently activates factors
that repair the damage. One consequence of checkpoint
activation is to increase dNTP production, which causes
about a 6- to 8-fold increase in dNTP pools after DNA
damage treatment (1). Transient up-regulation of dNTP
pools leads to increased resistance to DNA-damaging
agents, but also increased mutation rates (1).
Furthermore, constitutively high dNTP pools inhibit the
entry into S phase by delaying replication initiation and
also impair activation of the DNA damage checkpoint (2).
Therefore, proper dNTP regulation is crucial for cell
growth and DNA damage repair.
dNTP production is tightly controlled throughout the
cell cycle and in response to DNA damage. This is accom-
plished through the regulation of ribonucleotide reductase
(RNR), the enzyme that performs the rate-limiting step in
de novo synthesis of dNTPs (3). In most eukaryotes, the
RNR enzyme is a heterotetramer, comprised of one large
homodimeric R1 subunit and one small homodimeric R2
subunit. In Saccharomyces cerevisiae, there are four genes
(RNR1-4) that encode RNR polypeptides, but only
RNR1, RNR2 and RNR4 are essential (4–6). The yeast
enzyme is comprised of one homodimeric Rnr1 subunit,
as well as a heterodimeric Rnr2/Rnr4 subunit. Although
protein levels of the second large polypeptide, Rnr3,
increase dramatically in response to DNA damage, there
is no detectable growth or DNA repair defect for rnr3D
(7). However, Rnr3 is important for cell survival in
response to genotoxic stress when the target of rapamycin
(TOR) pathway is inhibited by Rapamycin treatment (8).
The regulation of RNR is multifaceted and includes
both allosteric regulation (9) and checkpoint-dependent
regulation controlled by the Mec1/Rad53/Dun1 kinases.
Following damage, Mec1, the ataxia telangiectasia-related
(ATR) homolog in yeast, is activated and initiates a kinase
cascade that controls many aspects of the DNA damage
response including cell-cycle progression, expression of
transcriptional targets, replication fork stability and
late-replication origin ﬁring (10). Additionally, all of the
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Dun1-dependent manner following checkpoint activation,
varying from about 3-fold for RNR1 to more than
100-fold for RNR3 (4–6,11). The RNR proteins are also
regulated by changes in their subcellular localization (12).
At all stages of the cell cycle, Rnr1 and Rnr3 are found in
the cytoplasm, where dNTP synthesis is thought to occur.
In contrast, Rnr2 and Rnr4, the small subunits, are
localized to the nucleus during G1 and are co-transported
to the cytoplasm during S phase and after DNA damage
treatment (13). Wtm1, a WD40-containing protein, is
involved in anchoring Rnr2 and Rnr4 to the nucleus in
G1 (14,15), while the cytoplasmic protein, Dif1, is
required for nuclear import of Rnr2 (16,17). In response
to DNA damage, Wtm1 releases the small RNR
heterodimeric subunit from the nucleus and Dif1 is
degraded, allowing Rnr2 and Rnr4 to remain in the cyto-
plasm (14–17).
In budding yeast, RNR is also regulated by the protein
inhibitor Sml1, which was ﬁrst identiﬁed as a suppressor
of the lethality of mec1 and rad53 mutations (18). A sml1D
mutation leads to increased levels of all four dNTPs
compared to wild type (18) and Sml1 binds to Rnr1 and
inhibits RNR activity in vitro (19,20). The Sml1 protein is
degraded in response to DNA damage and this regulation
is dependent on the Mec1, Rad53 and Dun1 checkpoint
kinases, mutations of which completely stabilize Sml1
(21). This degradation correlates with the appearance of
Dun1-dependent phosphorylated forms of Sml1 (21);
however, it was not shown directly whether this phosphor-
ylation is required for the degradation of the protein.
Puriﬁed Dun1 from yeast directly phosphorylates recom-
binant Sml1 in vitro and Sml1 physically interacts with
Dun1 in a two-hybrid assay (22). Additionally, three
serines in the Sml1 protein (56, 58 and 60) can be
phosphorylated by Dun1 in vitro (23). Recently, Sml1 deg-
radation was shown to be a very sensitive indicator of
DNA damage checkpoint activation (24) and its degrad-
ation occurs even when Rad53 phosphorylation is un-
detectable (25).
Ubiquitylation, an important post-translational modiﬁ-
cation, commonly targets proteins for degradation by the
26S proteasome [for review see Refs (26) and (27)]. Protein
ubiquitylation is controlled by a sequence of reactions
carried out by three types of conjugating enzymes: E1
(ubiquitin-activating enzyme), E2 (ubiquitin-conjugating
enzyme) and E3s (ubiquitin-protein ligases) as well as by
deubiquitylation enzymes. The E3 enzymes determine spe-
ciﬁcity for the target protein, and also regulate where the
ubiquitin will be added (28).
An E2 that is involved in the DNA damage response,
Rad6, associates with several E3 enzymes, including Ubr1,
Bre1 and Rad18 (29–31) and is known to ubiquitylate the
proliferating cell nuclear antigen (PCNA) and 9-1-1
clamps, among other targets (32,33). Rad6 has also been
shown to associate with the E3 Ubr2, which was dis-
covered due to its sequence homology to Ubr1 (34) and
was later shown to have a role in the ubiquitylation and
degradation of the proteasomal regulator Rpn4 (35).
Mub1 is an additional factor required for the
ubiquitylation of Rpn4 in vivo and in vitro (36).
In the present study, site-directed mutagenesis was used
to identify the in vivo phospho-acceptors important for
Sml1 degradation. Changing four serines (56, 58, 60 and
61) to alanines, sml1-4SA, prevents the degradation of the
protein by blocking its in vivo and in vitro Dun1 phosphor-
ylation.Endogenousexpressionofthesml1-4SAgenealone
does not aﬀect cell growth or DNA damage repair since
other forms of RNR regulation are still intact. However,
when sml-4SA is overexpressed, it slows S phase progres-
sion. Additionally, failure to degrade Sml1 is toxic when
Rnr1 function is compromised (rnr1-W688G). Sml1 phos-
phorylation is required for its degradation in response to
DNA damage. The degradation of Sml1 following DNA
damage treatment also depends on the Rad6–Ubr2–Mub1
E2/E3 ubiquitin complex. Our results suggest a model
whereby DNA damage-induced phosphorylation and
ubiquitylation of Sml1 occur sequentially triggering deg-
radation of Sml1 by the 26S proteasome.
MATERIALS AND METHODS
Strains and media
The strains used in this study are listed in Supplementary
Table S1. Sml1 phosphorylation was detected in strains
that have increased levels of Sml1 due to overexpression
of RNR1, which does not aﬀect the regulation or function
of Sml1 (21). In Figure 1D and Supplementary Figure S1,
strains were transformed with pWJ841, a 2-m plasmid that
carries RNR1 (21). All mutations were generated by
polymerase chain reaction (PCR). Integrations at the re-
spective chromosomal loci were done by the cloning-free
PCR-based allele replacement method (37). The correct
integration was veriﬁed through sequencing of an
ampliﬁed segment from the respective genomic region.
To distinguish between the diﬀerent alleles, mutations
were engineered to either introduce or delete a restriction
site: sml1-4SA is detected by loss of an MboII site;
rnr1-W688G has a new SfcI site. The chromosomal
GAL-SML1 locus described previously (21) was used to
make the GAL-sml1-4SA strain (W3332-5C). Media and
growth conditions used in all experiments are standard
(38) with the addition of twice the amount of leucine
(60mg/ml) in all synthetic complete (SC)-based media.
Cultures were grown in Yeast extract, peptone, dextrose
(YPD), SC or SC-dropout for plasmid selection. YPD or
Yeast extract, peptone, galactose (YPGal) contains 1%
yeast extract, 2% peptone and 2% glucose or 2% galact-
ose, respectively. YPGly (2% peptone, 1% yeast extract,
3% glycerol and 3% D-lactic acid) or YPRaﬃnose (1%
yeast extract, 2% peptone and 2% raﬃnose) medium was
used in experiments where galactose induction was
required. For the experiments in Figures 2 and 4D, cells
were grown in YPGly medium, pH 4.5, to facilitate the
induction of GAL-sml1 constructs. To synchronize cells in
G1, 3.4mg/ml a-factor was added for 2.5h. Galactose
(2%) induction was initiated in the last 30min of this
treatment and continued after the cells were released
from a-mating factor by rapid ﬁltration into YPGal
medium. S-phase progression was monitored by analysis
of the DNA content through ﬂow cytometry.
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Several methods of protein extraction were used to detect
protein levels. For the experiments in Figures 1C, 5A, C
and D; Supplementary Figure S1, extracts were made by
the ‘boiling method’ as described in ref. (21). For the ex-
periment in Figure 3C, protein extracts were prepared
by the trichloroacetic acid (TCA) method (39), and for
the experiments in Figure 1D, a variation of this experi-
ment using NP-40 extraction buﬀer (1% NP-40, 150mM
NaCl, 50mM Tris, pH 8.0) was performed. Immediately
before use, this buﬀer was supplemented with a protease
inhibitor cocktail (Roche, as per manufacturer’s
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Figure 1. Mutations that eliminate putative phosphorylation sites in Sml1 stabilize the protein after DNA damage treatment and prevent in vivo and
in vitro phosphorylation. (A) Depiction of the Sml1 protein with the positions of all serine and threonine residues that are potential phosphorylation
sites. The shaded regions indicate the positions of two a helices, including the C-terminal helix, which is important for Sml1 binding to Rnr1. The four
serines changed in the sml1-4SA mutant are shown in bold type. (B) Mid-log phase cultures of cells expressing YFP-Sml1 (W4622-14B), YFP-sml1-3SA
(W6976-4A) or YFP-sml1-4SA (W4748-4D) fusion proteins were treated with 100Gy of g-irradiation. Protein stability was examined by visualizing
YFP ﬂuorescence before and after treatment. White arrows indicate cells that are in S phase (small buds). The scale bar is equal to 3mm. (C) Total
yeast extracts of the strains shown in (B) were probed with anti-Sml1 antibody to examine stability and in vivo phosphorylation, as determined by
mobility shift of immunoblot, of the fusion proteins in logarithmically growing cultures. To control for loading, the membrane was stripped and
re-probed using anti-Adh1 antibody. (D) Total yeast extracts from wild-type (W1588-4C) and sml1-4SA (W3329-7D) strains were examined for Sml1
in vivo phosphorylation in response to treatment with g-irradiation (300Gy), 0.05% MMS and 4-NQO (0.25mg/l). The arrow indicates the position of
Sml1 proteins. The slower migrating bands (indicated by a bracket) are due to phosphorylation (21). Immunoblots were probed with anti-Sml1 serum.
The top band, labeled with an asterisk, is a Sml1-independent cross-reacting band used as a loading control. (E) Recombinant puriﬁed Sml1 and
sml1-4SA were incubated with GST-Dun1 fusion protein puriﬁed from yeast. A portion of the reaction was resolved on a 4–20% SDS–PAGE gradient
gel, stained with Coomassie blue and subsequently visualized by autoradiography for
32P incorporation. Both reactions contained the same amount of
recombinant protein (left) and exhibited the same level of kinase activity as observed by GST-Dun1 autophosphorylation (right).
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and 1mM DTT. Proteins were separated by SDS–PAGE,
transferred to polyvinylidene ﬂuoride membranes and
blots were probed with anti-Sml1 serum (21), anti-Rad53
antibody (Santa Cruz) or anti-Adh1 (alcohol dehydrogen-
ase) antibody (Chemicon International, AB1202). Sml1
bands were detected using ECL+(Amersham).
In vitro kinase assays
The ORFs of SML1 and sml1-4SA were PCR ampliﬁed
and cloned in the pET3a expression vector (Stratagene) to
generate plasmids pWJ1265 and pWJ1266, respectively
(primer sequences available on request). Recombinant
proteins were expressed in BL21(DE3)pLYS(S) bacteria
and puriﬁed as described previously (19). Expression of
pWJ772, a GST-Dun1 fusion protein (22), was induced
for 5h with 4% galactose in a pep4D strain exponentially
growing in SC-Ura medium with 2% raﬃnose.
Preparation of GST-Dun1 extracts and in vitro kinase
assays were carried out essentially as described previously
(22). A portion of the reaction was resolved on a 4–20%
SDS–PAGE gradient gel (Bio-Rad) then stained with
Coomassie blue R-250 (Bio-Rad) and subsequently
autoradiographed.
DNA damage sensitivity experiments
Exponential cultures were sonicated and plated at the ap-
propriate dilutions on YPD plates with methyl methane
sulfonate (MMS) or 4-nitroquinoline 1-oxide (4-NQO),
prepared 24h before the experiment. Cells were grown
at 30C and viable colonies were counted after 4 days.
DNA damage sensitivity experiments were repeated at
least three times and a minimum of two strains for each
genotype were tested.
YFP fusions, construction and ﬂuorescence microscopy
Yellow ﬂuorescent protein (YFP) and cyan ﬂuorescent
protein (CFP) fusions of the proteins (Sml1 variants,
Rnr1, Rnr2 and Rnr3) were made by the cloning-free
PCR-based allele replacement method and are at the cor-
responding chromosomal loci (40). All fusions are to the
N-terminal end of the proteins and are separated by an
eight-alanine linker. Cells were processed for diﬀerential
interference contrast (DIC) and ﬂuorescence microscopy
as described previously (41) and ﬂuorescence was
quantiﬁed using Openlab software (Improvision).
Two-hybrid construction and testing
Sml1 was cloned using primers BamHI_Sml1 and
Sml1_PstI. Ubr2 was cloned using SmaI_Ubr2 and
Ubr2_PstI. Mub1 was cloned using SmaI_Mub1
and Mub1_PstI. All primer sequences are available upon
request. PCR products from the Sml1 PCR were cut with
BamHI and PstI as inserted into pGAD-C2 and pGBD-C2
(42). Ubr2 and Mub1 PCR products were digested with
SmaI and PstI and inserted into pGAD-C1 and
pGBD-C1 (42). All pGAD derived plasmids, including
pGAD-C1, were transformed into PJ69-4A and all
pGBD-derived plasmids, including pGBD-C1, were trans-
formed into PJ69-4a (42). Strains containing pGBD-Sml1
and pGBD-Ubr2 were not further tested due to
autoactivation of the reporters. Strains containing
pGBD-C1, and pGBD-Mub1 were mated with strains con-
taining pGAD-C1, pGAD-Sml1 and pGAD-Ubr2.
Diploids were grown up overnight in medium lacking
LEU and TRP to select for plasmids. Strains were diluted
to an optical density (OD600)=1.0, were serially diluted
5-fold and spotted on to -LEU–TRP, and -LEU–TRP–
HIS plates. Plates were scanned after 4 days of growth.
RESULTS
Multiple serine to alanine changes in Sml1 stabilize the
protein after DNA damage treatment and prevent
in vivo and in vitro phosphorylation
Previously, we showed that the degradation of Sml1 after
DNA damage treatment depends on the MEC1/RAD53/
DUN1 checkpoint pathway and correlates with the
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Figure 2. Overexpression of sml1-4SA, but not SML1, slows S phase
progression in wild-type cells. (A) Wild-type and sml1-4SA strains were
analyzed for cell-cycle progression. There is no signiﬁcant diﬀerence in
the duration of S phase between the two strains when the proteins are
expressed endogenously (black lines to the right of the panels).
(B) Overexpression of sml1-4SA (W3332-5C), but not SML1
(W2056-8A), driven by a strong galactose promoter slows S phase
progression in wild-type cells. Black lines to the right of the panels
indicate S-phase.
Nucleic Acids Research, 2010,Vol.38, No. 19 6493phosphorylation of Sml1 (21). In addition, Dun1, a serine/
threonine kinase (43), phosphorylates Sml1 in vitro (22).
Since there are 13 serines and 4 threonines in the 104
amino acids Sml1 protein (Figure 1A), we used
site-directed mutagenesis to identify potential phosphoryl-
ation sites in Sml1 that would prevent Sml1 degradation
following DNA damage treatment. Notably, three serines
(56, 58 and 60) were found by Dealwis and colleagues (23)
to be phosphorylated by Dun1 in vitro. Although
mutation of these three serines to alanines, referred to as
sml1-3SA, results in a stable protein as determined by
ﬂuorescent microscopy (Figure 1B), this protein still
undergoes a mobility shift following DNA damage treat-
ment, likely resulting from phosphorylation (Figure 1C).
Therefore, Sml1 mutants containing diﬀerent combin-
ations of serine to alanine changes were examined by
ﬂuorescence microscopy and immunoblot for their stabil-
ity and phosphorylation state following g-irradiation
(data not shown). While many of the mutants are stable,
it was necessary to change four serines (56, 58, 60 and 61)
to alanines to block any detectable phosphorylation of
the protein, indicated by a mobility shift on the gel
(Figure 1C). Henceforth, we call this mutant sml1-4SA
because four serines were changed to alanines.
Protein levels and localization of Sml1 and sml1-4SA
were analyzed by visualizing the ﬂuorescence of
YFP-tagged fusion proteins. In unirradiated cells,
wild-type Sml1 levels are lower during S phase, while
sml1-4SA levels remain unaltered throughout the cell
cycle (Figure 1B, arrows). Furthermore, as shown in the
right panel of Figure 1B and in Figure 1C, wild-type Sml1
protein is completely degraded within an hour after
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Figure 3. RNR regulation and checkpoint activation are normal in a sml1-4SA strain. (A) Cells expressing YFP-Sml1 (W5530-6C) or YFP-sml1-4SA
(W5755-2A) along with CFP-Rnr1 were visualized by ﬂuorescent microscopy before and an hour after 200Gy of g-irradiation. Live cell images were
captured identically and YFP levels are depicted on the graphs. Cells without buds are G1 cells and were used for subsequent analyses. (B) Protein
extracts were taken from wild-type (W1588-4C) and sml1-4SA (W3329-7D) cells before and an hour after 0.03% MMS treatment and analyzed by
immunoblot using a Rad53 antibody. (C) Cells expressing both YFP-sml1-4SA and CFP-Rnr2 proteins (W5766-1D) were visualized by ﬂuorescent
microscopy before and an hour after 200Gy of g-irradiation. WT, wild-type strain.
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A similar result was observed on immunoblots of
untagged proteins using anti-Sml1 serum (Figure 1D).
YFP-Sml1 and YFP-sml1-4SA show the same dispersed
cytoplasmic localization. Using anti-GFP antibody as well
as ﬂuorescence intensity for quantiﬁcation, we ﬁnd that
the levels of YFP-sml1-4SA are 2- to 2.5-fold higher
compared to the levels of YFP-Sml1 in exponentially
growing cultures, indicating that YFP-sml1-4SA is
present at higher levels in the cell.
Next, we analyzed the in vivo phosphorylation state of
untagged sml1-4SA in response to a variety of DNA
damaging agents in the presence of RNR1 overexpression,
which facilitates detection of phosphorylated Sml1 on an
immunoblot (21). In wild-type cells, DNA damage treat-
ment results in the appearance of phosphorylated species
of Sml1 observed as a band or bands with reduced elec-
trophoretic mobility (Figure 1D, top) (21). No such bands
are seen in the sml1-4SA mutant, demonstrating the
absence of any detectable in vivo phosphorylation of the
sml1-4SA protein (Figure 1D, bottom).
The increased stability and undetectable
phosphorylated protein in the sml1-4SA strain following
DNA damage is reminiscent of Sml1 behavior in a dun1D
mutant. Therefore, we measured the phosphorylation of
the sml1-4SA mutant protein by Dun1 in vitro. While
GST-Dun1 puriﬁed from total yeast extracts phosphoryl-
ates wild-type Sml1 in vitro (22), it does not detectably
phosphorylate sml1-4SA mutant protein (Figure 1E).
The in vitro phosphorylation experiment is consistent
with the in vivo phosphorylation data suggesting that the
mutations in sml1-4SA prevent phosphorylation by Dun1.
Since we ﬁnd no detectable growth defect in a sml1-4SA
strain (Figure 2A), we investigated the eﬀect of
overexpressing the non-degradable sml1-4SA protein on
the cell cycle after release from G1 arrest. We conﬁrmed
that overexpression of wild-type Sml1 does not aﬀect entry
into or progression through the cell cycle (Figure 2B, ﬁrst
panel and ref. (21)). In contrast, overexpression of
sml1-4SA delays the start of and extends the progression
of S phase (Figure 2B, second panel). At 25min
post-release, most of the cells in the GAL-SML1 strain
have started DNA replication and by 50min the majority
of the DNA is replicated. Comparing the same time
points in the GAL-sml1-4SA strain shows that while
some DNA replication has initiated at 25min, the
majority is delayed 25min and initiation occurs at
the 50-min time point.
Taken together, these results show that changing the
four serines identiﬁed in our analyses to alanines likely
abolishes Sml1 phosphorylation by Dun1 both in vivo
and in vitro. Furthermore, the stability of the non-
phosphorylatable mutant sml1-4SA indicates that phos-
phorylation of Sml1 is essential to target the protein for
degradation after DNA damage.
Other aspects of dNTP regulation and checkpoint
activation are functional in sml1-4SA
While there are many facets to RNR regulation, their re-
lationships are not well understood. Therefore, we
investigated the induction of Rnr1 as well as the
relocalization of the small Rnr2 subunit from the
nucleus to the cytoplasm when Sml1 phosphorylation is
blocked. Using ﬂuorescently tagged proteins, Sml1 and
Rnr1 levels were analyzed before and after g-irradiation.
Both Sml1 and Rnr1 levels ﬂuctuate throughout the cell
cycle in unirradiated cells. After irradiation, all of the cells
are comparably arrested in G2/M. To eliminate the vari-
ability that occurs between diﬀerent cell-cycle stages in the
unirradiated samples, we only measured ﬂuorescence in
G1 cells. As previously shown in Figure 1B, YFP-Sml1
disappears after g-irradiation while YFP-sml1-4SA
remains stable (Figure 3A). It was previously reported
that Rnr1 protein levels increase about 2-fold following
DNA damage treatment (7). We also see a 2-fold increase
in endogenously tagged CFP-Rnr1 levels in wild-type cells
treated with g-irradiation (Figure 3A; bars 2 and 4).
Similarly, Rnr1 levels increase following DNA damage
treatment in sml1-4SA cells (Figure 2A; bars 6 and 8).
These results suggest that Rnr1 transcriptional regulation
is still intact in the sml1-4SA strain. Furthermore, in
unirradiated G1 cells, Rnr1 levels are increased in the
sml1-4SA strain compared to wild type (Figure 3A; bars
2 and 6; P<0.001). We suggest that this increase compen-
sates for the higher Sml1 levels in this strain during un-
perturbed growth and after DNA damage treatment.
In response to DNA damage treatment, Rad53 is
phosphorylated (44) and Rnr2 and Rnr4 move from the
nucleus to the cytoplasm (12). We examined these
upstream and downstream events in both wild-type and
sml1-4SA cells after g-irradiation. In contrast to untreated
cells, Rad53 is phosphorylated following MMS treatment
in both wild-type and sml1-4SA cells (Figure 3B). Thus,
checkpoint activation appears normal even in the absence
of Sml1 degradation. Additionally, when we examine a
downstream event, we ﬁnd that CFP-tagged Rnr2 moves
from the nucleus to the cytoplasm in both wild-type and
sml1-4SA cells after g-irradiation (data not shown and
Figure 3C). This result demonstrates that blocking phos-
phorylation and degradation of Sml1 does not aﬀect RNR
relocalization. Altogether, these experiments indicate that
the relative stability of the Sml1 protein does not aﬀect
these other aspects of the DNA damage response.
Sml1 protein down-regulation is necessary for survival of
mutants compromised in dNTP regulation
Unlike a dun1D strain, which is also defective in Sml1
degradation, a sml1-4SA strain is not sensitive to DNA
damaging agents (data not shown). We suspect that the
sml1-4SA mutant does not show increased DNA damage
sensitivity because other aspects of the DNA damage
response and of RNR regulation remain functional as
shown in Figure 3. To explore this question further,
sml1-4SA was combined with a mutation that is defective
in dNTP regulation: rnr1-W688G. We chose the
rnr1-W688G strain because it is particularly sensitive to
Sml1 regulation. This allele was isolated based on its
ability to physically interact with sml1 mutants that do
not bind to wild-type Rnr1 (45). Since rnr1-W688G can
also interact with wild-type Sml1, the mutation may cause
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to this view, rnr1-W688G causes increased sensitivity to
DNA damaging agents, which can be suppressed by
deleting SML1 (Figure 4A). In addition, rnr1-W688G
most likely leads to endogenous DNA damage, indicated
by the constitutive expression of YFP-Rnr3 in these cells
(Figure 4B).
Next, we analyzed the spores from a cross between an
rnr1-W688G strain and a sml1-4SA strain to test the
genetic interaction between stabilized Sml1 and this
sensitizing mutation. Genetic analysis of this diploid
shows that spores of the genotype rnr1-W688G
sml1-4SA are synthetic lethal (Figure 4C, left). This inter-
action is identical to that seen when the rnr1-W688G allele
is combined with dun1D (Figure 4C, right), which is also
defective for Sml1 degradation (22) as well as RNR
regulation (12,43). Furthermore, deletion of SML1
suppresses the synthetic lethality between rnr1-W688G
and dun1D (Figure 4C, right). Interestingly, the levels of
YFP-Sml1 ﬂuorescent protein in an unperturbed
rnr1-W688G strain are undetectable (data not shown),
also indicating that there is a constitutively active check-
point in this strain. However, even the low levels of Sml1
in an rnr1-W688G strain must account for some dNTP
inhibition, as deletion of SML1 rescues the severe petite
phenotype, indicative of low dNTP pools (18) observed in
an rnr1-W688G strain (data not shown). Taken together,
these results show that the degradation of Sml1 becomes
essential in the rnr1-W688G strain, likely due to the
aberrant regulation of this sensitized RNR subunit.
To more closely inspect the eﬀects of expressing Sml1
and sml1-4SA in the rnr1-W688G strain, both genes were
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Figure 4. sml1-4SA sensitizes cells that are defective in dNTP regulation. (A) rnr1-W688G is sensitive to genotoxic stress. The DNA damage
sensitivities of the strains [wild type (W1588-4C), rnr1-W688G (W4383-1B) and rnr1-W688G sml1D (W4383-10C)] were examined in a quantitative
survival assay used to determine the LD50 values after 4-NQO (mg/l) and MMS (%) treatments. Mid-log phase cultures were sonicated and
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promoter. Transient overexpression of either Sml1 or
sml1-4SA in the rnr1-W688G mutant has a dramatic
eﬀect on growth. For example, the rnr1-W688G strain is
sensitive to increased levels of wild-type Sml1 since entry
into S phase is signiﬁcantly delayed (Figure 4D, ﬁrst panel;
Figure 2B). However, these cells do resume the cell cycle
and continue to grow. On the other hand, overexpression
of sml1-4SA in the rnr1-W688G strain completely blocks
entry into S phase after release from G1 (Figure 4D,
second panel). This result provides an explanation for
the lethality of the rnr1-W688G sml1-4SA double mutant
shown in Figure 4C, namely, it is unable to progress
through S phase.
Sml1 degradation is dependent on the 26S proteasome as
well as the RAD6–UBR2–MUB1 ubiquitin ligase complex
Phosphorylation isoftenasignalforsubstratestargetedfor
degradation by the 26S proteasome via ubiquitylation
(46,47). To determine whether Sml1 degradation is de-
pendent on the 26S proteasome, Sml1 stability after
DNA damage treatment was examined following inactiva-
tion of two essential genes of the proteasome (48,49).
Figure 5A shows that Sml1 protein degradation is
impaired in the temperature-sensitive mutants, pre1-1 or
pre2-2, at the restrictive temperature (50).
To determine the ubiquitin ligase(s) responsible for the
ubiquitylation of Sml1, we introduced a YFP-Sml1
plasmid into all 36 of the known non-essential E3 ubiqui-
tin ligases (Supplementary Table S2). Sml1 stability was
examined by ﬂuorescent microscopy following 100Gy of
g-irradiation and YFP-Sml1 was only stable in the ubr2D
strain (data not shown). Ubr2 has previously been shown
to interact with the Rad6 E2 ubiquitin conjugating
enzyme and with Mub1, an E2/E3 interacting protein
(35,36). This complex ubiquitylates Rpn4, a transcription
factor involved in the biosynthesis of proteasome compo-
nents (35,36). Therefore, we introduced a YFP-Sml1
plasmid into rad6D and mub1D strains and found that
YFP-Sml1 is also stable following DNA damage treat-
ment. Notably, stabilization of YFP-Sml1 following
100Gy of g-irradiation is not seen in deletions of any of
the other six known non-essential E2s (Supplementary
Table S2) (data not shown).
To avoid potential problems associated with
plasmid-based expression of YFP-Sml1, a genomic copy
of YFP-Sml1 was introduced into the rad6D, ubr2D and
mub1D genetic backgrounds. In addition, Ubr1 is a known
interactor with Rad6 (30) and shows homology with Ubr2
(34). Therefore, we also introduced a genomic copy of
YFP-Sml1 into a ubr1D strain. Fluorescent protein levels
were examined in all strains before and after DNA
damage treatment. As shown in Figure 5B, YFP-Sml1 is
degraded within 40min following treatment with 100Gy
of g-irradiation in both wild-type and ubr1D strains, but is
stable in rad6D, ubr2D, and mub1D strains. Furthermore,
endogenous levels of Sml1 are higher in the rad6D, ubr2D,
and mub1D mutants, even in the absence of DNA damage.
Next, YFP-Sml1 protein from these strains was examined
by immunoblot following g-irradiation (Figure 5C). In
wild-type cells at 20min post damage, a slower migrating
band appears, which is consistent with phosphorylation of
the protein (Figure 1C) and this band is degraded at
45min post-irradiation. Similar results are also observed
in a ubr1D mutant. Interestingly, in rad6D, ubr2D and
mub1D mutants, this slower migrating band is seen even
in the absence of DNA damage treatment and accumu-
lates post-DNA damage with no noticeable degradation.
Next, the non-phosphorylatable YFP-sml1-4SA was
introduced into the rad6D, ubr2D, mub1D, ubr1D
mutants and a wild-type strain and immunoblots were
performed following DNA damage treatment. As seen in
Figure 5D, the slower migrating band observed in Figure
5C is absent, consistent with the notion that this is the
phosphorylated form of Sml1. In addition, as expected
(Figure 1D), the YFP-sml1-4SA protein is stable following
DNA damage treatment in all strains. Finally, untagged
Sml1 is more stable in rad6D, ubr2D and mub1D strains
following 100Gy of g-irradiation compared to wild-type
and ubr1D strains (Supplementary Figure S1).
Mub1 has been implicated in the substrate speciﬁcity of
the E2/E3 complex during the ubiquitylation of Rpn4
(36). Using a two-hybrid approach, we investigated the
interactions between Ubr2, Mub1 and Sml1.
Unfortunately, GBD-Sml1 and GBD-Ubr2 show
non-speciﬁc interactions with an empty GAD construct
and could not be tested further (data not shown). On
the other hand, GBD-Mub1 shows an interaction with
GAD-Ubr2 conﬁrming results found previously (36).
Interestingly, GBD-Mub1 also interacts with GAD-Sml1
indicating a direct link between these two proteins
(Figure 5E).
DISCUSSION
Sml1, a regulator of RNR, is phosphorylated and
degraded in response to DNA damage treatment (22).
Although the precise serine residue(s) that is/are
phosphorylated is not known, we show that it is necessary
to change four serines to alanines in the Sml1 protein to
eliminate any detectable phosphorylation in vivo
(Figure 1C and data not shown). There are numerous
examples of phosphorylation at multiple sites to control
protein stability. The detailed analysis of Sic1, a cell-cycle
regulator and a substrate of the SCF
Cdc4 complex,
showed that phosphorylation at any six, but not ﬁve, of
the nine possible phosphorylation sites, targets it for
ubiquitylation and degradation (51). In another example,
mutation of six phospho-acceptor residues in FANCI
is necessary to abolish its phosphorylation,
monoubiquitylation, focus formation and DNA repair
activity (52). Thus, the number of phosphorylated
residues, rather than their position, is often more import-
ant for targeting a protein for degradation. Furthermore,
the amino acid sequence at the site that we identiﬁed in
Sml1 contains multiple serines in close proximity
(SASASS), making it unlikely that phosphorylation at a
particular site is important. Recently, a small cytoplasmic
protein, Dif1, was shown to be required for Rnr2 import
into the nucleus (16,17). Interestingly, Dif1 shares
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mutated in sml1-4SA (56, 60 and 61). Since Dif1 is also
phosphorylated and degraded in a Dun1-dependent
manner, perhaps it shares a similar mechanism for deg-
radation with Sml1.
The serine to alanine mutations in sml1-4SA completely
block detectable phosphorylation and degradation of the
protein. However, the non-degradable protein does not
alter cell survival or resistance to DNA damage unless
sml1-4SA is combined with a mutation that further
impairs RNR activity (Figure 3C). Our results conﬁrm
that dNTP regulation is robust and there is a discernible
biological eﬀect only when multiple components of this
regulation are eliminated. For example, a dun1D strain is
DNA damage sensitive, since it aﬀects dNTP regulation
not only by preventing Sml1 degradation, but also by af-
fecting induction of the RNR genes, as well as the
relocalization of the R2 subunit. However, in a
sml1-4SA strain, only sml1-4SA stability is aﬀected,
while other aspects of RNR regulation are normal
(Figure 3). In addition, there is a small but signiﬁcant
increase in Rnr1 levels in a sml1-4SA strain compared to
wild type (Figure 3A, bars 2 and 6; P<0.001). We suggest
that cells expressing the non-degradable sml1-4SA com-
pensate for low dNTP pools by increasing RNR1
transcription.
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proteasome (Figure 5A). Screening the 36 known
non-essential E3 enzymes, we found that Ubr2 is
required for Sml1 degradation (Figure 5B). Ubr2
ubiquitylates the transcription factor, Rpn4, in concert
with the Rad6 E2 ligase and the Mub1 proteins (35,36),
and both of these proteins are also important for Sml1
degradation (Figure 5). Since Rpn4 is involved in the regu-
lation of proteasomal genes (53), its stability in ubr2D,
rad6D and/or mub1D mutants could potentially lead to
an increase in proteasomes. Up-regulation of proteasomal
subunits due to increased Rpn4 levels would in fact desta-
bilize Sml1, making it unlikely that these mutants are
having an indirect eﬀect on Sml1 stability. Furthermore,
the two-hybrid experiment demonstrates a direct inter-
action between Mub1 and Sml1 (Figure 5D). Therefore,
Ubr2, Rad6 and Mub1 likely ubiquitylate Sml1 directly,
leading to its degradation in response to DNA damage.
This E2/E3 complex may also be involved in the turnover
of Sml1 protein during S phase, since increased levels of
phosphorylated Sml are observed in ubr2D, rad6D and
mub1D strains even without DNA damage treatment
(Figure 5C).
Although Rad6, in conjunction with several E3 ubiqui-
tin ligases, has many targets in the DNA damage pathway
including PCNA and members of the 9-1-1 complex
(29–33), this is the ﬁrst interaction, to our knowledge,
that also requires the Ubr2/Mub1 proteins. Sml1 protein
localizes to the cytoplasm where it is bound to Rnr1
(Figure 1B and (12)). Ubr2 is also found in the cytoplasm
(54), perhaps facilitating Sml1 ubiquitylation. It will be
important to determine whether the Rad6–Ubr2–Mub1
complex ubiquitylates other DNA damage-regulated
proteins. Of particular interest is Dif1, another
cytoplasmically localized protein, which shares
homology with Sml1 and is involved in dNTP regulation
(16,17).
Taken together, our results can be summarized in a
model describing Sml1 modiﬁcations that target the
protein for degradation in response to DNA damage
(Figure 6). In this model, before DNA damage, Sml1 is
bound to Rnr1, inhibiting RNR activity. Following DNA
damage, the Mec1/Rad53/Dun1 kinase cascade is
activated and phosphorylates Sml1. This phosphorylation
triggers a conformational change in Sml1 leading to its
dissociation from Rnr1. Phosphorylated Sml1 is
recognized by the Rad6–Ubr2–Mub1 E2/E3 ligase
complex, which ubiquitylates Sml1 targeting it for degrad-
ation by the 26S proteasome. In the end, loss of Rnr1
inhibition after Sml1 degradation allows the formation
of an active RNR enzyme leading to an increase in the
production of dNTPs to facilitate DNA damage repair.
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